Skip to content
Home/Companies/Biotech/Caprion Biosciences
CB

Caprion Biosciences

Biotech·Canada·Exited 2019·Held 3yr

Caprion Biosciences is a biotech company, headquartered in Canada.

Entry
2016
Hold
3yr
Exit
2019
Est. EV
–

Who owns Caprion Biosciences?

Caprion Biosciences was owned by GHO Capital through GHO Capital Fund I LP (2015 vintage) from 2016 to 2019, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

GHO Capital
Investor
GHO Capital
GHO Capital Fund I LP · 2015 · Buyout

Key facts

HQCanada
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2019

More from GHO Capital Fund I LP

Other portfolio companies in the same fund.

BioAgilytix
Exited 2021
BiotechUnited States· 2018
to
VISUfarma
Exited 2026
PharmaUK· 2016
to
DNA Diagnostics Center
Exited 2021
HealthcareUnited States· 2015
to
Quotient Sciences
Exited 2019
PharmaUK· 2015
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings